Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
844.60
806.00
804.30
766.20
698.20
748.50
746.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
844.60
806.00
804.30
766.20
698.20
748.50
746.90
Raw Material Cost
548.10
500.90
510.80
493.00
465.50
474.10
481.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.90
0.00
0.10
0.10
0.40
0.00
0.70
Selling and Distribution Expenses
98.00
107.00
102.70
95.90
88.00
85.30
81.90
Other Expenses
1.39
2.18
1.70
1.90
1.59
1.85
1.48
Total Expenditure (Excl Depreciation)
661.90
629.70
630.60
608.00
569.80
577.90
579.10
Operating Profit (PBDIT) excl Other Income
182.7
176.29999999999998
173.70000000000002
158.2
128.4
170.6
167.8
Other Income
3.70
1.10
2.40
2.00
2.20
1.20
4.20
Operating Profit (PBDIT)
231.60
224.40
219.10
201.60
170.60
212.50
212.20
Interest
1.90
0.00
0.10
0.10
0.40
0.00
0.70
Exceptional Items
-4.40
-15.90
-4.10
-3.10
-19.70
-6.90
-6.80
Gross Profit (PBDT)
296.50
305.10
293.50
273.20
232.70
274.40
265.20
Depreciation
45.20
47.00
43.00
41.40
40.00
40.70
40.20
Profit Before Tax
180.10
161.50
171.90
157.00
110.50
164.90
164.50
Tax
44.70
33.30
34.00
30.20
24.10
36.80
32.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
138.80
132.10
140.00
131.80
89.80
130.10
136.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
138.80
132.10
140.00
131.80
89.80
130.10
136.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
138.80
132.10
140.00
131.80
89.80
130.10
136.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.25
0.25
0.25
0.25
0.25
0.25
0.25
Reserves
2,990.40
3,176.00
3,051.50
2,929.10
2,683.10
2,682.30
2,752.10
Earnings per share (EPS)
1.92
1.82
1.93
1.82
1.23
1.77
1.85
Diluted Earnings per share
1.92
1.82
1.93
1.82
1.23
1.77
1.85
Operating Profit Margin (Excl OI)
21.63%
21.87%
21.6%
20.65%
18.39%
22.79%
22.47%
Gross Profit Margin
26.68%
25.87%
26.72%
25.89%
21.56%
27.47%
27.41%
PAT Margin
16.43%
16.39%
17.41%
17.2%
12.86%
17.38%
18.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.79% vs 0.21% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 5.07% vs -5.64% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 2.06% vs 3.05% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of West Pharmaceutical Services, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
844.60
5,131.00
-4,286.40
-83.54%
Other Operating Income
0.00
0.00
0.00
Total Operating income
844.60
5,131.00
-4,286.40
-83.54%
Raw Material Cost
548.10
3,175.00
-2,626.90
-82.74%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.90
134.00
-132.10
-98.58%
Selling and Distribution Expenses
98.00
1,028.00
-930.00
-90.47%
Other Expenses
1.39
21.10
-19.71
-93.41%
Total Expenditure (Excl Depreciation)
661.90
4,548.00
-3,886.10
-85.45%
Operating Profit (PBDIT) excl Other Income
182.70
583.00
-400.30
-68.66%
Other Income
3.70
118.00
-114.30
-96.86%
Operating Profit (PBDIT)
231.60
854.00
-622.40
-72.88%
Interest
1.90
134.00
-132.10
-98.58%
Exceptional Items
-4.40
-62.00
57.60
92.90%
Gross Profit (PBDT)
296.50
1,956.00
-1,659.50
-84.84%
Depreciation
45.20
153.00
-107.80
-70.46%
Profit Before Tax
180.10
505.00
-324.90
-64.34%
Tax
44.70
94.00
-49.30
-52.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
138.80
389.00
-250.20
-64.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
138.80
389.00
-250.20
-64.32%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
22.00
-22.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
138.80
411.00
-272.20
-66.23%
Equity Capital
0
0
0.00
Face Value
0.25
0.01
0.00
Reserves
2,990.40
10,668.00
-7,677.60
-71.97%
Earnings per share (EPS)
1.92
0.85
1.07
125.88%
Diluted Earnings per share
1.92
0.85
1.07
125.88%
Operating Profit Margin (Excl OI)
21.63%
11.36%
0.00
10.27%
Gross Profit Margin
26.68%
12.82%
0.00
13.86%
PAT Margin
16.43%
7.58%
0.00
8.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 84.46 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 4.79% vs 0.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 20.97% vs 0.42% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.88 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 5.07% vs -5.64% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 54.57% vs -22.12% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.79 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 2.06% vs 3.05% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 35.33% vs 3.57% in Mar 2025
Quarterly - Interest
Interest 0.19 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 375.00% vs -73.33% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.63%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
